Conclusion
In view of the possible coexistence of scleroderma with MM, it is
suggested that all patients with scleroderma should be screened for
monoclonal gammopathy and MM regarding their age. Also, future studies
should be directed to determine the exact mechanism of these two
conditions association and the effect of MM treatment on SSc
improvement.